JONES FINANCIAL COMPANIES LLLP
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 815917
DES PERES, MO
Position in AMRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$675,222
+$673,307 QoQ
Shares Held
54,322
+35638.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 98.3413718198888.ToString("F0")%
Shared 0.ToString("F0")%
None 1.658628180111189.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JONES FINANCIAL COMPANIES LLLP holds $151,859,373 across 48 Drug Manufacturers - Specialty & Generic names. AMRX ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
9,086,528 | $90,956,145 | |
| 2 | ZTS |
Zoetis Inc.
|
179,646 | $21,235,953 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
250,151 | $14,826,449 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
321,219 | $9,675,116 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
2,135,741 | $5,851,930 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
23,151 | $3,049,911 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,960 | $1,755,220 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
54,322 | $675,222 |
All Filings in AMRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $675,222 | 54,322 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,915 | 152 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $500 | 50 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $404 | 50 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $419 | 50 | Shares | Sole | 2025-05-28 | |
| No filing history on record for this holder in this stock. | ||||||